[Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000471:Alkalosis / Q000188:drug therapy / Q000209:etiology*; D001201:Ascites / Q000188:drug therapy*; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000627:therapeutic use*; D004573:Electrolytes / Q000378:metabolism; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D004232:Diuretics; D004573:Electrolytes; D006852:Hydrochlorothiazide; D013148:Spironolactone; D005665:Furosemide; D004976:Ethacrynic Acid; D011188:Potassium
Trattamento diuretico ed alcalosi metabolica nella cirrosi epatica ascitica.